@Full-Oncology

Full-Oncology is a moderately active trader on Polymarket with 1,039 trades across 203 markets over 115 days. Despite a high total trading volume of over $2.19 million, their net profit and loss stands at a significant loss of $15,429.65, placing them at rank #2,962,318 on the global PnL leaderboard. Their performance metrics, including a low Smart Score of 15/100 and a negative Sharpe Ratio of -0.03, indicate early-stage experience and challenges in achieving consistent profitability.

The trader’s strategy appears to involve high-volume, manual trading with a contrarian and high-risk style, as suggested by their badges: Contrarian, Whale, and High Roller. Full-Oncology maintains a low win rate of 35% and a profit factor near 1, implying close to break-even outcomes but with frequent losses. Their trading behavior involves limited selling (11%) and no exposure to weather markets. The equity trend is downward, and their portfolio value has declined to zero, pointing to difficulties in timing and risk management.

Strengths of Full-Oncology include high engagement and volume, which could provide valuable learning opportunities and market insights over time. However, the significant net losses, poor risk-adjusted returns, and low win rate highlight potential concerns around strategy effectiveness and capital preservation. For Polymarket traders observing Full-Oncology, the data suggests caution and a need for refining approach before expecting sustainable gains.